Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Revenue (2019 - 2025)

Silo Pharma's Revenue history spans 7 years, with the latest figure at $18025.0 for Q3 2025.

  • For Q3 2025, Revenue changed 0.0% year-over-year to $18025.0; the TTM value through Sep 2025 reached $72102.0, changed 0.0%, while the annual FY2024 figure was $72102.0, 0.0% changed from the prior year.
  • Revenue for Q3 2025 was $18025.0 at Silo Pharma, roughly flat from $18025.0 in the prior quarter.
  • Across five years, Revenue topped out at $86148.0 in Q1 2022 and bottomed at -$483.0 in Q3 2021.
  • The 5-year median for Revenue is $18025.5 (2022), against an average of $24186.1.
  • The largest YoY upside for Revenue was 16033.67% in 2021 against a maximum downside of 102.97% in 2021.
  • A 5-year view of Revenue shows it stood at -$164.0 in 2021, then skyrocketed by 11091.46% to $18026.0 in 2022, then changed by 0.0% to $18026.0 in 2023, then changed by 0.0% to $18026.0 in 2024, then fell by 0.01% to $18025.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Revenue are $18025.0 (Q3 2025), $18025.0 (Q2 2025), and $18026.0 (Q1 2025).